can he or its been advertised wrongly? also is the option to place both bisected grafts at the recipient?
will the prices ever be for humans?
and when will he release info on hst 2.0?
very interesting quastions i believe for us all
will the prices ever be for humans?
and when will he release info on hst 2.0?
very interesting quastions i believe for us all
But generally the market tends to be right. Histogen's results were totally unimpressive. Aderans is indeed done. And Follica we don't know much about. The dermarolling community trial is interesting though. But all in all, I don't have much hope for something in the next 5 years ...
Comment